Remove company astrazeneca
article thumbnail

Court rules for drugmakers over HHS in 340B fight over contract pharmacies

Healthcare Dive

The decision is a win for drug manufacturers Sanofi, Novo Nordisk and AstraZeneca. The companies sued the HHS after regulators ordered them to stop restricting sales of 340B drugs to contract pharmacies.

242
242
article thumbnail

AstraZeneca Acquires Fusion Pharmaceuticals for $2B to Bolster Radioconjugate Pipeline

HIT Consultant

What You Should Know: AstraZeneca has entered into a definitive agreement to acquire Fusion Pharmaceuticals Inc., a clinical-stage biopharmaceutical company developing next-generation radioconjugates (RCs). Under the agreement, AstraZeneca will purchase all outstanding shares of Fusion at $21.00

98
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

C2i Genomics & AstraZeneca Partner to Advance Cancer Therapy

HIT Consultant

What You Should Know: – C2i Genomics , a cancer intelligence company, today announced a strategic collaboration with AstraZeneca , a global life sciences and pharmaceutical leader. – The two companies have collaborated to evaluate the potential of whole-genome minimal residual disease (MRD) testing across solid cancers.

98
article thumbnail

AstraZeneca working with Mass General on tech for heart failure, asthma

Healthcare IT News - Telehealth

The biotechnology company AstraZeneca announced on Tuesday that it would be collaborating with Massachusetts General Hospital to create and clinically validate patient-centric digital health solutions. WHY IT MATTERS. Slavin, president of Massachusetts General Hospital. THE LARGER TREND.

article thumbnail

AstraZeneca Acquires Icosavax for $1.1B to Advance RSV and hMPV Vaccine Development

HIT Consultant

What You Should Know: – AstraZeneca has announced the acquisition of Icosavax , a biopharmaceutical company developing a promising vaccine targeting both RSV and hMPV, for a total of up to $1.1 Financial Details AstraZeneca will acquire all outstanding Icosavax shares for $15.00 A contingent value right of up to $5.00

article thumbnail

AstraZeneca Forms Health Tech Business, Evinova to Deliver Digital Health Solutions for Life Sciences

HIT Consultant

What You Should Know: – AstraZeneca , a global biopharmaceutical company, has announced the launch of Evinova, a new business venture dedicated to providing cutting-edge digital health solutions that address the evolving needs of healthcare professionals, regulators, and patients.

52
article thumbnail

Life science companies unite on AI efforts through Israel's Aion Lab

Mobi Health News

The lab, which works with AstraZeneca, Merck, Pfizer, Israel Biotech Fund and Teva Pharmaceuticals, as well as tech company Amazon Web Services, is currently accepting new applicants for its new challenge.

81